Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

GABAergic mechanisms in epilepsy.

D M Treiman1

  • 1Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, NJ 08901, U.S.A. treiman@umdnj.edu

Epilepsia
|August 25, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characteristics of falls in the epilepsy monitoring unit: a retrospective study.

Epilepsy & behavior : E&B·2013
Same author

Brain dynamical disentrainment by anti-epileptic drugs in rat and human status epilepticus.

Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference·2007
Same author

Status epilepticus and tiagabine therapy: review of safety data and epidemiologic comparisons.

Epilepsia·2001
Same author

Therapy of status epilepticus in adults and children.

Current opinion in neurology·2001
Same author

Neocortical status epilepticus.

Advances in neurology·2000
Same author

Altered residual ATP content in rat brain cortex subcellular fractions following status epilepticus induced by lithium and pilocarpine.

Journal of molecular neuroscience : MN·1999

Gamma-aminobutyric acid (GABA) is crucial for balancing brain excitation and inhibition. Enhancing GABAergic function, through drugs like vigabatrin and tiagabine, offers potent anticonvulsant effects for epilepsy treatment.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Epilepsy Research

Background:

  • Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the cerebral cortex, essential for maintaining neuronal excitation-inhibition balance.
  • Perturbations in this balance can lead to seizures, highlighting the critical role of GABAergic signaling in neurological health.
  • GABA acts via GABAA and GABAB receptors, influencing ion flow and neurotransmitter release, with its levels regulated by synthesis, uptake, and catabolism.

Purpose of the Study:

  • To explore the significant role of GABA in the mechanisms and treatment of epilepsy.
  • To review evidence linking GABAergic dysfunction to epilepsy.
  • To discuss the mechanisms of novel antiepileptic drugs that modulate GABAergic neurotransmission.

Main Methods:

Related Experiment Videos

  • Review of experimental and clinical studies on GABAergic function in epilepsy.
  • Analysis of findings from animal models and human epileptic brain tissue.
  • Examination of the pharmacological actions of GABA agonists, antagonists, and modulators.

Main Results:

  • Abnormalities in GABAergic function are consistently observed in various epilepsy models and human epileptic brain tissue.
  • Reduced GABA-mediated inhibition and altered GABA levels/activity correlate with epilepsy.
  • GABA agonists demonstrate anticonvulsant properties, while antagonists can induce seizures.

Conclusions:

  • GABAergic neurotransmission is fundamentally implicated in the pathophysiology and treatment of epilepsy.
  • Drugs that enhance synaptic GABA levels, such as vigabatrin and tiagabine, are effective anticonvulsants.
  • Distinct mechanisms of action for GABA-modulating drugs may explain differences in their side-effect profiles.